Giri Ramsingh

Giri Ramsingh

Company: Gilead Sciences

Job title: Executive Director


Discussing Efficacy & Safety Data for CD47-Targeting Therapy 12:00 pm

• Sharing patient outcomes, toxicology studies, and dose escalation rationale • Considering the safety concerns of a ubiquitously expressed target such as CD47, and the toxicity seen in the clinic • Translating CD47 therapies to show targeting and validation of targetsRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.